This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Harada, M. Articles by Robbins, P. F. Search for Related Content PubMed PubMed Citation Articles by Harada, M. Articles by Robbins, P. F.

Use of an in Vitro Immunoselected Tumor Line to Identify Shared Melanoma Antigens Recognized by HLA-A*0201-restricted T Cells

Department of Virology, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan [M. H.]; and Surgery Branch, National Cancer Institute, NIH, Bethesda, Maryland 20892 [Y. F. L., M. E-G., S. A. R., P. F. R.]

An immunoselected melanoma cell line that had lost expression of the dominant melanoma antigens MART-1 and gp100 was generated in an attempt to identify previously unknown tumor antigens. After repeated stimulation with the autologous immunoselected tumor line, a number of HLA-A*0201-restricted T-cell clones were established from the peripheral blood of a single melanoma patient. One T-cell clone (C-22) recognized 14 of 16 HLA-A2⁺ melanoma cell lines, as well as HLA-A2⁺ melanocytes but recognized neither HLA-A2⁺ fibroblasts nor autologous B cells. Screening of an autologous cDNA library resulted in the isolation of a transcript identical to an entry in the expressed sequence tag database. Northern blot analysis revealed that this gene was expressed in most melanoma cell lines and melanocytes but not in normal tissues. The peptide epitope (AMFGREFCYA) recognized by clone C-22 was identified based on studies of the recognition of truncated cDNAs and the use of the consensus HLA-A*0201 binding motif. A second T-cell clone (C-29) was found to recognize a new tyrosinase-related protein 2 epitope (455-463; YAIDLPVSV) in an HLA-A*0201-restricted manner. Together, these results provide additional targets that can be used for the development of immunotherapeutic protocols in HLA-A2⁺ melanoma patients and demonstrate the utility of immunoselected tumor lines for the identification of new melanoma antigens.

This article has been cited by other articles:

				U. Gunnarsson, A. R. Hellstrom, M. Tixier-Boichard, F. Minvielle, B. Bed'hom, S. Ito, P. Jensen, A. Rattink, A. Vereijken, and L. Andersson Mutations in SLC45A2 Cause Plumage Color Variation in Chicken and Japanese Quail Genetics, February 1, 2007; 175(2): 867 - 877. [Abstract] [Full Text] [PDF]

				M. Soejima, H. Tachida, T. Ishida, A. Sano, and Y. Koda Evidence for Recent Positive Selection at the Human AIM1 Locus in a European Population Mol. Biol. Evol., January 1, 2006; 23(1): 179 - 188. [Abstract] [Full Text] [PDF]

				A. Paschen, M. Song, W. Osen, X. D. Nguyen, J. Mueller-Berghaus, D. Fink, N. Daniel, M. Donzeau, W. Nagel, H. Kropshofer, et al. Detection of Spontaneous CD4+ T-Cell Responses in Melanoma Patients against a Tyrosinase-Related Protein-2-Derived Epitope Identified in HLA-DRB1*0301 Transgenic Mice Clin. Cancer Res., July 15, 2005; 11(14): 5241 - 5247. [Abstract] [Full Text] [PDF]

				G. Denkberg, E. Klechevsky, and Y. Reiter Modification of a Tumor-Derived Peptide at an HLA-A2 Anchor Residue Can Alter the Conformation of the MHC-Peptide Complex: Probing with TCR-Like Recombinant Antibodies J. Immunol., October 15, 2002; 169(8): 4399 - 4407. [Abstract] [Full Text] [PDF]

				H. T. Khong and S. A. Rosenberg Pre-Existing Immunity to Tyrosinase-Related Protein (TRP)-2, a New TRP-2 Isoform, and the NY-ESO-1 Melanoma Antigen in a Patient with a Dramatic Response to Immunotherapy J. Immunol., January 15, 2002; 168(2): 951 - 956. [Abstract] [Full Text] [PDF]

				J. Du and D. E. Fisher Identification of Aim-1 as the underwhite Mouse Mutant and Its Transcriptional Regulation by MITF J. Biol. Chem., January 4, 2002; 277(1): 402 - 406. [Abstract] [Full Text]

				S. Akilesh, M. E. Dudley, P. A. Eden, and D. C. Roopenian Efficient Chromosomal Mapping of a Methylcholanthrene- Induced Tumor Antigen by CTL Immunoselection J. Immunol., November 1, 2001; 167(9): 5143 - 5149. [Abstract] [Full Text] [PDF]

				A. K. Sharma, J. J. Kuhns, S. Yan, R. H. Friedline, B. Long, R. Tisch, and E. J. Collins Class I Major Histocompatibility Complex Anchor Substitutions Alter the Conformation of T Cell Receptor Contacts J. Biol. Chem., June 8, 2001; 276(24): 21443 - 21449. [Abstract] [Full Text] [PDF]